Evidence map›Paper›PMID 29370086›Full record

ArticleCancers2018

Cell-Penetrating CaCO₃ Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma.

Viviana Vergaro, Monica Civallero, Cinzia Citti, Maria Cosenza, Francesca Baldassarre, Giuseppe Cannazza, Samantha Pozzi, Stefano Sacchi, Francesco Paolo Fanizzi, Giuseppe Ciccarella

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. CaCOMaterials (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Viviana VergaroDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce, Campus Universitario, Via Monteroni, 73100 Lecce, Italy. viviana.vergaro@unisalento.it.ORCID 0000-0003-3706-6276
Monica CivalleroDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena & Reggio Emilia, via Campi 287, 41125 Modena, Italy. francesca.baldassarre@unisalento.it.
Cinzia CittiDipartimento di Scienze della Vita, Università di Modena e Reggio Emilia, Via Campi 103, 41125 Modena, Italy. cinzia.citti@unimore.it.
Maria CosenzaDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena & Reggio Emilia, via Campi 287, 41125 Modena, Italy. monica.civallero@unimore.it.
Francesca BaldassarreDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce, Campus Universitario, Via Monteroni, 73100 Lecce, Italy. maria.cosenza@unimore.it.
Giuseppe CannazzaDipartimento di Scienze della Vita, Università di Modena e Reggio Emilia, Via Campi 103, 41125 Modena, Italy. giuseppe.cannazza@unimore.it.
Samantha PozziDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena & Reggio Emilia, via Campi 287, 41125 Modena, Italy. samantha.pozzi@unimore.it.
Stefano SacchiDipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena & Reggio Emilia, via Campi 287, 41125 Modena, Italy. stefano.sacchi@unimore.it.
Francesco Paolo FanizziDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento, Via Monteroni, 73100 Lecce, Italy. fp.fanizzi@unisalento.it.ORCID 0000-0003-3073-5772
Giuseppe CiccarellaDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce, Campus Universitario, Via Monteroni, 73100 Lecce, Italy. giuseppe.ciccarella@unisalento.it.ORCID 0000-0003-4467-0922
University of Modena and Reggio Emilia · ITUniversity of Salento · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to their nano-sized porous structure, CaCO₃ nanocrystals (CaCO₃NCs) hold the promise to be utilized as desired materials for encapsulating molecules which demonstrate wide promise in drug delivery. We evaluate the possibility to encapsulate and release NVP-BEZ235, a novel and potent dual PI3K/mTOR inhibitor that is currently in phase I/II clinical trials for advanced solid tumors, from the CaCO₃NCs. Its chemical nature shows some intrinsic limitations which induce to administer high doses leading to toxicity; to overcome these problems, here we proposed a strategy to enhance its intracellular penetration and its biological activity. Pristine CaCO₃ NCs biocompatibility, cell interactions and internalization in in vitro experiments on T-cell lymphoma line, were studied. Confocal microscopy was used to monitor NCs-cell interactions and cellular uptake. We have further investigated the interaction nature and release mechanism of drug loaded/released within/from the NCs using an alternative approach based on liquid chromatography coupled to mass spectrometry. Our approach provides a good loading efficiency, therefore this drug delivery system was validated for biological activity in T-cell lymphoma: the anti-proliferative test and western blot results are very interesting because the proposed nano-formulation has an efficiency higher than free drug at the same nominal concentration.

Indexed as

CaCO3 nanocrystalsdrug deliverymass spectrometrynanomedicineNVP-BEZ235T-cell lymphoma

Identifiers

PMID29370086
PMCPMC5836063
OpenAlexW2794352423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.